SpringWorks Therapeutics, Inc.
SWTX
$37.06
-$0.86-2.27%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -77.30M | -53.53M | -39.92M | -87.39M | -94.32M |
| Total Depreciation and Amortization | 1.02M | 878.00K | 844.00K | 729.00K | 538.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 28.12M | 28.45M | 28.46M | 31.89M | 27.38M |
| Change in Net Operating Assets | 18.66M | -1.18M | -31.18M | -24.16M | 3.70M |
| Cash from Operations | -29.50M | -25.38M | -41.79M | -78.93M | -62.71M |
| Capital Expenditure | -1.05M | -1.85M | -975.00K | -577.00K | 2.30M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 15.20M | 30.50M | 1.26M | 22.04M | -161.51M |
| Cash from Investing | 14.15M | 28.65M | 289.00K | 21.46M | -159.21M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 1.18M | 1.79M | 4.29M | 5.95M | 299.32M |
| Repurchase of Common Stock | -523.00K | -499.00K | -919.00K | -6.50M | -253.00K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 653.00K | 1.29M | 3.37M | -552.00K | 299.07M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -14.70M | 4.56M | -38.13M | -58.02M | 77.16M |